Revenue
2018
2019
2020
2021
2022
2023
2024
2025
AtriCure, Inc. (ATRC)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $534.5M | $465.3M | $399.2M | $330.4M | $274.3M | $206.5M | $230.8M | $201.6M | $174.7M | $155.1M | $129.8M | $107.5M | $81.9M | $70.2M | $64.4M | $59.0M | $54.5M |
| Gross profit | $400.8M | $347.5M | $300.4M | $245.9M | $205.9M | $149.3M | $170.3M | $147.1M | $126.2M | $111.1M | $92.9M | $75.8M | $59.6M | $50.0M | $47.0M | $45.4M | $41.8M |
| Research & development | $99.2M | $96.2M | $73.9M | $57.3M | $48.5M | $43.1M | $41.2M | $34.7M | $34.1M | $35.8M | $25.7M | $18.6M | $13.4M | $12.1M | $11.9M | $11.5M | $11.4M |
| Operating expenses | $410.2M | $387.5M | $327.1M | $288.6M | $150.7M | $193.5M | $203.5M | $164.2M | $151.1M | $142.2M | $119.6M | $92.1M | $70.5M | $57.2M | $51.7M | $48.6M | $57.3M |
| Operating income | −$9.4M | −$40.0M | −$26.7M | −$42.7M | $55.2M | −$44.2M | −$33.1M | −$17.1M | −$25.0M | −$31.1M | −$26.7M | −$16.4M | −$10.9M | −$7.2M | −$4.7M | −$3.2M | −$15.5M |
| EBITDAderived | $11.1M | −$21.3M | −$11.9M | −$31.0M | $65.6M | −$34.7M | −$23.8M | −$8.4M | −$15.9M | −$21.8M | −$20.4M | −$11.6M | −$8.9M | −$5.3M | −$2.8M | −$829,000 | −$13.1M |
| Net income | −$11.4M | −$44.7M | −$30.4M | −$46.5M | $50.2M | −$48.2M | −$35.2M | −$21.1M | −$26.9M | −$33.3M | −$27.2M | −$16.2M | −$11.5M | −$7.5M | −$5.5M | −$3.8M | −$16.5M |
| Basic EPSper diluted share | -$0.24 | -$0.95 | -$0.66 | -$1.02 | $1.11 | -$1.14 | -$0.94 | -$0.62 | -$0.83 | -$1.05 | -$0.97 | -$0.61 | -$0.56 | -$0.47 | -$0.35 | -$0.25 | -$1.13 |
| Diluted EPSper diluted share | -$0.24 | -$0.95 | -$0.66 | -$1.02 | $1.09 | -$1.14 | -$0.94 | -$0.62 | -$0.83 | -$1.05 | -$0.97 | -$0.61 | -$0.56 | -$0.47 | -$0.35 | -$0.25 | -$1.13 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 20, 2026Form 4 | Prange KarenDirector | SellCommon Stock | 3.0K | $28.65 | $86.0K | 26.4K |
| May 15, 2026Form 4 | Doraiswamy VinayakChief Scientific Officer | SellCommon Stock | 5.0K | $28.13 | $140.7K | 91.9K |
| Mar 12, 2026Form 4 | Doraiswamy VinayakChief Scientific Officer | SellCommon Stock | 5.0K | $29.83 | $149.2K | 96.9K |
| Nov 26, 2025Form 4 | Noznesky Justin JChief Mktg & Strategy Officer | SellCommon Stock | 5.2K | $37.29 | $192.6K | 78.8K |
| Nov 25, 2025Form 4 | WEHRWEIN SVENDirector | SellCommon Stock | 5.0K | $38.00 | $188.7K | 34.4K |